Welcome to NicOx

.Creating value through therapeutic innovation

About NicOx

Development

Maximizing portfolio

People

Investor & media

Profile
Pipeline
Medical Education Grants

	**News......**

	4 August 2010		NicOx to close US headquarters





	30 July 2010		NicOx first half 2010 financial results


			Conference call on NicOx's 2010 Half Year Financial Results

			Presentation PDF available





	22 July 2010		FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod





	28 June 2010		Presentation of preclinical data for NicOx's ophthalmology candidate NCX 434

NicOx is a pharmaceutical company dedicated to the development of nitric oxide-donating drug-candidates for unmet medical needs.

NicOx is targeting the therapeutic areas of inflammatory, cardiometabolic and ophthalmological diseases.

NicOx aims to build itself into a specialty pharmaceutical company, with its own commercial operations in the United States.